Targeted healing: A new stent concept that could contribute to shortened DAPT
This advertorial is sponsored by Sinomed
As newer-generation drug-eluting stent (DES) technol...
Patients at high risk of bleeding—A forgotten population in PCI?
There is an increasing understanding of the need for tailored strategies when treating high-bleedin...
Intravascular lithotripsy: Not an eccentric option for eccentric calcium
This advertorial is sponsored by Shockwave Medical.
Severe coronary artery calcification presents...
RE-ACCESS study has implications for TAVI valve selection
This advertorial is sponsored by Boston Scientific
In recent years, transcatheter aortic valv...
FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool
This advertorial is sponsored by PIE Medical
Findings of the multicentre FAST II clinical tri...
Leaflex: Changing the conversation around aortic stenosis?
This advertorial is sponsored by Pi-Cardia
As more transcatheter aortic valve implantation (TAVI)...
Preventing kidney damage in the cath lab
This advertorial is sponsored by Osprey Medical
There is a growing recognition of the risk of con...
ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?
This advertorial is sponsored by Boston Scientific
Results of the SCOPE II clinical trial wer...
Robotics and advanced imaging provide protection and precision in PCI
This article, part of an educational supplement sponsored by Siemens Healthineers, details the use...
The challenges of the modern cath lab
Over the last decade, the cath lab has transformed. Interventional cardiologists are now not only tr...
A variety of tools are now available for physiological assessment
Multiple studies have shown that fractional flow reserve (FFR) is a valuable modality for assessing ...
Make confident diagnostic decisions on coronary artery diseases – fast
In this educational supplement, sponsored by Siemens Healthineers, Cardiovascular News explores ...
Tailoring therapy and maximising TAVI programme efficiency
In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use...
ADVERTORIAL: Further data underline the critical role of Impella Heart Pumps in Protected PCI
Findings from an interim analysis of PROTECT III have added to the evidence for improved outcome...
ADVERTORIAL: Answering the question of durability is TAVI’s next challenge
Over the past few years, the indications for transcatheter aortic valve implantation (TAVI) have...
ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking” reduction in mitral regurgitation
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI
Caution: This content is only for readers outside of France and Japan. In the US, ACURATE neo is...
ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with considerable improvement in functional outcomes
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are encouraging
The Duke Children’s Pediatric & Congenital Heart Center (Duke University Medical Center, Dur...
ADVERTORIAL: “We are now at a new era of TAVI where we have very high rates of device success”
CAUTION: The ACURATE neo aortic valve system is CE marked. In the USA, it is an investigational ...
ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
ADVERTORIAL: Rethinking the future of cardiology imaging
This content is only for readers outside of the USA
In an environment with growing demand for...
ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for under-treated patients
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough
This content is for distribution within the UK only.
This content is for distribution wit...
Contemporary Issues in Complete Revascularisation
This educational supplement is only for readers in countries outside Europe.
In this e...
LAA closure for stroke prophylaxis in atrial fibrillation
This educational supplement is only for readers in countries outside France, Japan and the USA
In...
Siemens Healthineers’ unique imaging technologies: Smart solutions for challenging patients
In this supplement,* Cardiovascular News reviews how unique imaging technologies provide smart solut...
Current issues in PCI: The latest data
The first edition of Current issues in PCI, which was published as a supplement alongside the Februa...
Current issues in PCI
The Stenting in Complex PCI meeting (2 December 2014, Milan, Italy) reviewed some of the most import...
DAPT and DES in coronary artery disease: Is it time to revisit the guidelines?
At a roundtable organised by Cardiovascular News, with an unrestricted educational grant from Medtro...
“Orsiro is a great example of some of the latest developments in DES technology”
Cardiovascular News interviews Francesco Bedogni from Sant’Ambrogio Hospital, Milan, Italy, on the d...
